OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Clinical and Translational Neurology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	117
The case of a 49‐year‐old man with involuntary toe movements	103
Issue Information	79
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights	69
The Case of a 25‐Year‐Old Woman With Isolated Head Tremor	67
Discrepant expressive language lateralization in children and adolescents with epilepsy	62
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐	61
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	61
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	49
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	44
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	44
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	43
Order from chaos: Using CSF proteomics to predict ALS progression	43
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	42
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	42
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	41
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab	40
Association of serum Spp1 levels with disease progression in ALS and SBMA	40
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	40
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	39
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	39
Peripheral nervous system manifestations of MOG antibody associated disease	39
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	38
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	37
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	37

Cognitive impairment in pulmonary arterial hypertension	37
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	36
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	36
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability	35
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	35
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	35
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	34
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	34
Issue Information	34